Oxytocin and the development of attachment: Looking beyond the expected?
- Conditions
- General healthy population children (ages 8 - 13 years old).Therapeutic area: Psychiatry and Psychology [F] - Psychological processes [F02]
- Registration Number
- EUCTR2022-000156-11-BE
- Lead Sponsor
- KU Leuven
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 200
General population children between the age of 8 and 13 years old.
Are the trial subjects under 18? yes
Number of subjects for this age range: 200
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
- Participant has a history of an oxytocin allergy
- Any disorder, which in the Investigator’s opinion might jeopardise the participant’s safety or
compliance with the protocol
- Any prior or concomitant treatment(s) that might jeopardise the participant’s safety or that
would compromise the integrity of the Trial
- Participation in an interventional Trial with an investigational medicinal product (IMP) or device
- A kidney or cardial condition.
- Participant is taking any medication at the time of testing.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method